SEC Filings | Allogene Therapeutics

Filing date	Description	Form	View
Apr 24, 2023	Additional proxy soliciting materials - definitive	DEFA14A	0001737287-23-000043.pdf 0001737287-23-000043.rtf 0001737287-23-000043.xls View HTML
Apr 24, 2019	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001193125-19-115774.pdf 0001193125-19-115774.rtf 0001193125-19-115774.xls View HTML
Apr 23, 2020	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-20-000021.pdf 0001737287-20-000021.rtf 0001737287-20-000021.xls View HTML
Apr 22, 2021	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-21-000013.pdf 0001737287-21-000013.rtf 0001737287-21-000013.xls View HTML
Apr 26, 2022	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-22-000026.pdf 0001737287-22-000026.rtf 0001737287-22-000026.xls View HTML
Apr 24, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	0001737287-23-000041.pdf 0001737287-23-000041.rtf 0001737287-23-000041.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 19, 2018		D	0001737287-18-000001.pdf 0001737287-18-000001.rtf 0001737287-18-000001.xls View HTML
Oct 11, 2018	CT ORDER	CT ORDER	9999999997-18-008531.pdf 9999999997-18-008531.rtf View HTML
Oct 25, 2021	CT ORDER	CT ORDER	9999999997-21-005550.pdf View HTML
Oct 04, 2018	CORRESP	CORRESP	0001193125-18-293829.pdf 0001193125-18-293829.rtf 0001193125-18-293829.xls View HTML

Data provided by Kaleidoscope.